Andreas Krause
Andreas Krause
Lead Scientist Modeling & Simulation at Idorsia Pharmaceuticals Ltd
Verifierad e-postadress på
Citeras av
Citeras av
A standard curve based method for relative real time PCR data processing
A Larionov, A Krause, W Miller
BMC bioinformatics 6 (1), 1-16, 2005
Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole
MJ Ellis, Y Tao, O Young, S White, AD Proia, J Murray, L Renshaw, ...
Journal of clinical oncology 24 (19), 3019-3025, 2006
The basics of S-Plus
A Krause, M Olson
Springer Science & Business Media, 2005
Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies
A Scherer, A Krause, JR Walker, A Korn, D Niese, F Raulf
Transplantation 75 (8), 1323-1330, 2003
Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole
WR Miller, A Larionov, L Renshaw, TJ Anderson, JR Walker, A Krause, ...
J Clin Oncol 27 (9), 1382-1387, 2009
Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole
WR Miller, AA Larionov, L Renshaw, TJ Anderson, S White, J Murray, ...
Pharmacogenetics and genomics 17 (10), 813-826, 2007
Drug development for pediatric populations: regulatory aspects
J Zisowsky, A Krause, J Dingemanse
Pharmaceutics 2 (4), 364-388, 2010
The validation of new aromatase monoclonal antibodies for immunohistochemistry—a correlation with biochemical activities in 46 cases of breast cancer
H Sasano, TJ Anderson, SG Silverberg, RJ Santen, M Conway, ...
The Journal of steroid biochemistry and molecular biology 95 (1-5), 35-39, 2005
Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib
P Bono, A Krause, M von Mehren, MC Heinrich, CD Blanke, S Dimitrijevic, ...
Blood 103 (8), 2929-2935, 2004
Efficacy of rivastigmine in Alzheimer’s disease patients with rapid disease progression: results of a meta-analysis
MR Farlow, GW Small, P Quarg, A Krause
Dementia and geriatric cognitive disorders 20 (2-3), 192-197, 2005
Optimized protocol for linear RNA amplification and application to gene expression profiling of human renal biopsies
A Scherer, A Krause, JR Walker, SE Sutton, D Seron, F Raulf, MP Cooke
Biotechniques 34 (3), 546-556, 2003
Identifying interesting genes with siggenes
H Schwender, A Krause, K Ickstadt
The Newsletter of the R Project Volume 6/5, December 2006 6, 45, 2006
An integrated view of aromatase and its inhibition
WR Miller, TJ Anderson, DB Evans, A Krause, G Hampton, JM Dixon
The Journal of steroid biochemistry and molecular biology 86 (3-5), 413-421, 2003
Multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P1 receptor modulator: Favorable impact of dose up‐titration
P Brossard, M Scherz, A Halabi, H Maatouk, A Krause, J Dingemanse
The Journal of Clinical Pharmacology 54 (2), 179-188, 2014
Modeling of Discontinuous Relationships in Biology with Censored Regression
B Schmid, W Polasek, J Weiner, A Krause, P Stoll
The American Naturalist 143 (3), 494-507, 1994
A picture is worth a thousand tables: graphics in life sciences
A Krause, M OConnell
Springer Science & Business Media, 2012
Visualization and communication of pharmacometric models with Berkeley Madonna
A Krause, PJ Lowe
CPT: pharmacometrics & systems pharmacology 3 (5), 1-20, 2014
Aromatase inhibitors: cellular and molecular effects
WR Miller, TJ Anderson, S White, A Larionov, J Murray, D Evans, ...
The Journal of steroid biochemistry and molecular biology 95 (1-5), 83-89, 2005
Clinical and biomarker endpoint analysis in neoadjuvant endocrine therapy trials
Y Tao, A Klause, A Vickers, K Bae, M Ellis
The Journal of Steroid Biochemistry and Molecular Biology 95 (1-5), 91-95, 2005
Applied statistics in the pharmaceutical industry: with case studies using S-Plus
SP Millard, A Krause
Springer Science & Business Media, 2013
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20